Skip to content

SIMPLIFYING

COMPLEXITY

IN NEW & BETTER WAYS

Solutions Helping BioInnovators to Quickly Identify and Connect with Emerging BioStartups to Speedup Core Innovations.

READ MORE

CONNECTING SMART PEOPLE

MAKE THE WORLD

YOUR LABORATORY

PROVIDING SOLUTIONS TO QUICKLY IDENTIFY EMERGING TECHNOLOGIES MATCHES TO SCALE UP YOUR INNOVATIONS.

READ MORE

CONNECTING INNOVATIONS

UNCOVER NEW

OPPORTUNITIES

PROVIDING FOCUSED NEW LEADS MATCHING YOUR CORE BUSINESS NEEDS.... OPENING IMMENSE NEW POSSIBILITIES.

READ MORE

CONNECTING BUSINESSES

Mapping innovations

Innovations in Drug Discovery & Development are growing exponentially across the Globe. As a Business Leader, Real Challenge lies in routine mapping of Individual Events to identify Emerging New Business Opportunities.

We at OmicsX provides an instant, ready to use solutions to ease your routine tasks and helping your team to stay ahead and updated.

Intelligence @ Fingertips

FALL IN LOVE with Our Solutions

Eagle's Eye View

Solutions in form of Comprehensive Market Intelligence Reports, with largest sectoral coverage provides an Instant Holistic view and total business opportunities within the Sector.

Trusted Information

Every piece of Intelligence is backed by Factual Information. No guess work; only Facts and Figures.

BioStartups Connections

Customized Solutions helping CRO's to spot and Connect with Emerging Startups worldwide, thus helping both in identifying new business opportunities and Speeding up Core Innovations.

Everything in Budget

Keeping everything up and running with a minimal Intelligence budget.

INTELLIGENCE REPORTS &

PREBUILD READY TO USE CRMS PLATFORM

01

identify new opportunities

TWO Oncology reports

360 Degree Insights on Drug Development

  • 2485 Active Cancer Drug Developers.
  • 4725 Active Molecules in Development.
  • 1600+ Deals & Partnering Details.
  • Special coverage on CAR-T, Vaccines, ADCs, Monoclonal Antibodies, Oncolytic Viruses and Small molecule Kinase Inhibitors.
  • Emerging Technologies like Microbiome, CRISPER, Exosomes, RNAi etc., as Cancer treatment are covered.

Oncology Clinical Drug Intelligence- 2024

World's Largest Insights based on Active 1235 Clinical Stage Oncology Drug Developers
-----------------------------------------
Includes Insights on
Companies | Technologies
Pipeline | Targets | Deals | Funding

Details

Report provides an extensive coverage on Oncology Drug Development and includes World’s Largest Number of Active Clinical Stage Oncology Drug Developers. (1235 Companies Profiles)

1450+ Pages provides, in-depth Analysis on

  • GLOBAL 1235 CLINICAL STAGE ONCOLOGY DRUG DEVELOPERS.
  • 2730 CANCER TARGETING MOLECULES IN DEVELOPMENT.
  • EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
  • ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
  • INDIVIDUAL COMPANY FUNDING STATUS

Report opens an immense opportunities to New Business Development.
Explore More

Show

Single Source Solution to Reach-out and connect World’s Largest Number of Active Early Stage Oncology Drug Developers. (1250 Companies).

945 Pages Report contains in-depth Analysis on

  • 1250 ACTIVE COMPANIES PROFILE
  • 1200+ CANCER TARGETING MOLECULES IN DEVELOPMENT.
  • EMERGING CANCER DRUG TARGETS & PROPERITORY TECHNOLOGIES.
  • ONCOLOGY FOCUSED DEALS & PARTNERING ACTIVITIES.
  • INDIVIDUAL COMPANY FUNDING STATUS, and much more. 

Report opens an immense opportunities to New Business Development.
Explore More

Show

Oncology PreClinical Drug Intelligence 2024

World's Largest Insights covering 1250 Active PreClinical Stage Oncology Drug Developers
-----------------------------------------
Includes Insights on
Companies | Technologies
Pipeline | Targets | Deals | Funding

Details

Region SpecificOncology Drug Intelligence ReportsEurope The United States of America The Greater China RegionLatest InsightsCheck collectionFurther Details

See it in action2024Released - June 2024Europe'sOncology Drug Development Landscape
Further Details2025To be Released in Sep 2024The United States of AmericaOncology Drug Development Landscape
Further Details2025To be Released in Oct 2024Oncology Drug Development LandscapeThe Greater China Region

02

IDENTIFY & CONNECT

Social Sales & Marketing CRM platform

Don’t Manage Contacts…

Engage Them

highly innovative

Prebuilt Social CRMS with Intelligence

03

NEW BUSINESS DEVELOPMENT TOOLKIT

Oncology Toolkit 2024

YOUR Profit Accelerator...

gain minimum 20%
more business

Complete Oncology Intelligence

+

Prebuild Key Accounts Social CRMS

"self explanatory intelligence provided my team to quickly identify our needs and help us to reshape our marketing efforts..."
Jassica Doe
Director - Business Development

Trusted by

BUSINESS LEADERS -WORLDWIDE

Start Accelerating  your business today!

Newsletter 

Subscribe for News Updates and Product Offers.
* we never share your e-mail with third parties.